Client News

invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors

Abivax receives “Capital Market Transaction of the Year Award” at the European Mediscience Awards 2023

Digital health start-up Capreolos GmbH launches Ready4OP app to support patients before major surgical procedures

Medigene AG: Medigene to Host Virtual R&D Event on TCR-T Therapies for Solid Tumors

ITM Opens World’s Largest Lutetium-177 Production Facility for Targeted Radionuclide Therapies Against Cancer

Biotalys announces closing of private placement

Abivax stock included in MSCI indexes

Biotalys Strengthens Relationship with Investors via Private Placement of New Shares for €7 million

Abivax releases the results of its June 5, 2023 ordinary and extraordinary general meeting

Carbios aims to be a leader in growing r-PET market with an ambition to capture 8 to 12% share by 2035 through licensing model